Good morning, and welcome to the Wednesday email.
Once a week we pick three stories, read the documents behind them, and pull out the lines worth knowing. This week all three come back to one question: who checked? Mounjaro's own label prints a study on the pill. Researchers ordered semaglutide with no prescription and sent what arrived to a lab. And a prosecutors' memo describes what one peptide company did to its lab reports.
Each story links to the full article if you want the rest.
The pill may not work as well
This one matters to anyone on Mounjaro who also takes the pill.
That line sits in Mounjaro's own patient leaflet. In the study the label prints, the pill's hormones peaked 55 to 66 percent lower after one dose. The warning covers the four weeks after starting, and four weeks again after every increase.
Why it matters: the same leaflet says, "It is not known if MOUNJARO will harm your unborn baby." We looked for a study that counts the pregnancies. We found none.
Read the full story: Is Mounjaro Making Your Birth Control Fail?
Six orders. Three never came.
Researchers wanted to know what really shows up when you buy semaglutide, the drug in Ozempic, from websites that ask for no prescription. So they placed six orders.
Three never arrived, and those sellers asked for up to 1,200 dollars more. The other three did arrive, each sold as 99 percent pure.
The fine print: the six sellers were picked as the riskiest, in 2023. It is one small study, and we found no larger one that tested these orders.
Read the full story: 6 No-Prescription Semaglutide Orders. Only 3 Showed Up.
Who made the lab report?
A lab report is supposed to prove what is in the vial. Prosecutors say one peptide company, with more than 54,000 customers, forged its reports. Their memo says it edited other businesses' certificates and took the lab's contact details off them.
The owner got 70 months in prison. Six of the company's products, labeled as SARMs, all tested as testosterone.
The fine print: the memo reports no test of any of its peptides.
Read the full story: A Peptide Seller Got 70 Months. Who Made Your Lab Report?
Every compound we track, with its grade and its sources, is on the Table.
Open the TableThat's the week. See you next Wednesday.
Ask better questions.
The Peptide Table